# Enabling AI-Assisted Pharmacometric Workflows Under Data Constraints:  
## A Structure-Preserving Synthetic Data Approach

## Abstract

Recent advances in AI-assisted coding and agentic workflows have the potential to significantly accelerate pharmacometric analysis. However, their application in clinical settings is constrained by strict data access controls, which limit the use of external tools on sensitive clinical trial datasets. This creates a practical bottleneck: modern AI tools are most effective in flexible local or cloud-based environments, while clinical data must remain within restricted systems.

We propose a workflow pattern for enabling AI-assisted analysis under these constraints by decoupling dataset structure from sensitive patient-level values. This is implemented through structure-preserving synthetic datasets that retain key statistical and modeling characteristics (e.g., covariate distributions, dosing structure, and observation patterns) while containing no real patient data.

Using representative pharmacometric workflows, we demonstrate how synthetic datasets can be used to develop, test, and refine analysis code and AI-assisted pipelines in unrestricted environments. Final model fitting and validation are then performed on real data within secure systems, preserving data integrity and regulatory compliance. This approach enables the practical use of modern AI tools without exposing sensitive data or compromising reproducibility.

While demonstrated using synthetic data, this work reflects a broader class of workflow patterns for integrating AI into regulated scientific environments. These patterns emphasize separation of analysis from decision-making, explicit handling of data constraints, and preservation of scientific accountability. By focusing on concrete, reproducible workflows, this approach provides a practical path for adopting AI in pharmacometrics without weakening governance or trust.